Accuray (ARAY) Other Non-Current Assets (2011 - 2026)
Accuray's (ARAY) quarterly Other Non-Current Assets came in at $26.4 million in Q1 2026, up 23.72% year-on-year from $21.3 million in Q1 2025, and up 552.82% quarter-over-quarter from $4.0 million in Q4 2025.
Accuray (ARAY) Other Non-Current Assets (2011 - 2026) Analysis & Trends
Accuray's Other Non-Current Assets history runs 16 years deep, the most recent figure standing at $26.4 million for Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 23.72% year-over-year to $26.4 million in Q1 2026; TTM through Mar 2026 was $26.4 million, a 23.72% increase from a year earlier, with the FY2025 full-year figure at $24.4 million, up 1728.2% from the prior year.
- Other Non-Current Assets climbed to $26.4 million in Q1 2026 per ARAY's latest filing, from $4.0 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $26.4 million in Q1 2026 and bottomed at $1.2 million in Q2 2022.
- The 5-year median for Other Non-Current Assets is $18.4 million (2022), against an average of $12.6 million.
- Across the five-year window, Other Non-Current Assets plunged 94.2% in 2023 and surged 1728.2% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $1.3 million in 2022, then jumped by 1639.6% to $22.5 million in 2023, then decreased by 2.0% to $22.0 million in 2024, then tumbled by 81.67% to $4.0 million in 2025, then jumped by 552.82% to $26.4 million in 2026.
- Per Business Quant, the three latest ARAY Other Non-Current Assets figures stand at $26.4 million (Q1 2026), $4.0 million (Q4 2025), and $3.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Accuray | 29,832.96 | -38.50 Mn | 25.29 Mn | 26.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.37 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Sep 30, 2025 | 3.88 Mn |
| Jun 30, 2025 | 24.44 Mn |
| Mar 31, 2025 | 21.32 Mn |
| Dec 31, 2024 | 22.04 Mn |
| Sep 30, 2024 | 19.72 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 21.74 Mn |
| Dec 31, 2023 | 22.49 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 21.53 Mn |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 18.39 Mn |
| Dec 31, 2021 | 1.26 Mn |
| Sep 30, 2021 | 1.26 Mn |
| Jun 30, 2021 | 16.87 Mn |